ID   NCC-RbC-60
AC   CVCL_4073
SY   NCC-RbC-R60; R60
DR   CLO; CLO_0050131
DR   BioSample; SAMN03472020
DR   JCRB; JCRB1326
DR   JCRB; NIHS0501
DR   RCB; RCB2213
DR   Wikidata; Q54907627
RX   PubMed=7499444;
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: 47 hours (PubMed=8263010).
CC   Discontinued: JCRB; NIHS0501; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001696.
ST   Source(s): JCRB; RCB
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=7499444; DOI=10.1007/BF01213319;
RA   Inomata M., Saijo N., Kawashima K., Kaneko A., Fujiwara Y.,
RA   Kunikane H., Tanaka Y.;
RT   "Induction of apoptosis in cultured retinoblastoma cells by the
RT   protein phosphatase inhibitor, okadaic acid.";
RL   J. Cancer Res. Clin. Oncol. 121:729-738(1995).
//
RX   PubMed=8263010; DOI=10.1007/BF01202193;
RA   Inomata M., Kaneko A., Saijo N., Tokura S.;
RT   "Culture of retinoblastoma cells from clinical specimens:
RT   growth-promoting effect of 2-mercaptoethanol.";
RL   J. Cancer Res. Clin. Oncol. 120:149-155(1994).
//